2019 Vaccines for Adults

Awarded Award Notice Posted

Solicitation number
75D301-19-R-67894
Agency
CDC Office of Acquisition Services Centers for Disease Control and Prevention, Department of Health and Human Services
Awarded
Set-aside
No set-aside

Opportunity facts

NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
Not on record

Notice details come from SAM.gov. Updated .

About this opportunity

This Award Notice from the Centers for Disease Control and Prevention seeks proposals for indefinite delivery, indefinite quantity contracts to supply minimum and maximum quantities of 13 adult vaccines, with 12-month minimum shelf lives, to various immunization programs. The CDC's National Center for Immunization and Respiratory Diseases requires between 100 and 850,000 doses of each specified vaccine to be delivered within 15 days of order receipt under firm fixed price contracts valued at an estimated total amount not provided. The period of performance is 12 months from award.

Notice text

3 versions

Update #3 · Latest ·

AWARD NOTICE:


Contract Award of 6 Centers for Disease Control Vaccine for Adults (VFA) Contracts:



200-2019-05105 - Merck Sharp & Dohme Corp
Award Amount: $86,407,050.00


200-2019-05106 - Sanofi Pasteur Inc.
Award Amount: $36,351,538.70


200-2019-05107 - Dynavax Technologies Corporation
Award Amount: $26,156,250.00


200-2019-05108 - GlaxoSmithKline LLC
Award Amount: $112,644,450.00
200-2019-05109 - Grifols, USA
Award Amount: $1,602,700.00


200-2019-05110 - Pfizer Inc.
Award Amount: $46,031,000.00


This is a firm-fixed price, indefinite delivery/indefinite quantity delivery contract for the purchase of standard commercial vaccines described herein, manufactured under a current establishment and product license issued by the U.S. Food and Drug Administration. The period of performance is 7/1/2019 - 6/30/2020.


.

Update #2 ·

Due date revised..

Update #1 ·

The Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD) requires the award of one or more indefinite quantity, indefinite delivery contracts for the purchase of the following adult vaccines and estimated quantities manufactured under a current establishment and product license issued by the U.S. Food and Drug Administration:

Item Descriptions & Quantities:



1. Hepatitis A adult vaccine:
Min. Shelf Life: 12 Months
Fed. Excise Tax: tiny_mce_marker.75 per dose
Maximum: 775,000 Doses
Minimum: 100 Doses



2. Hepatitis B adult vaccine:
Min. Shelf Life: 12 Months
Fed. Excise Tax: tiny_mce_marker.75 per dose
Maximum: 375,000 Doses
Minimum: 100 Doses



3. Hepatitis A & B combination adult vaccine:
Min. Shelf Life: 12 Months
Fed. Excise Tax: $1.50 per dose
Maximum: 275,000 Doses
Minimum: 100 Doses



4. Pneumococcal Polysaccharide vaccine:
Min. Shelf Life: 12 Months
Fed. Excise Tax: N/A
Maximum: 500,000 Doses
Minimum: 100 Doses



5. Tetanus and Diphtheria Toxoids vaccine for adults
Min. Shelf Life: 12 Months
Fed. Excise Tax: $1.50 per dose
Maximum: 100,000 Doses
Minimum: 100 Doses



6. Herpes Zoster vaccine for adults
Min. Shelf Life: 12 Months
Fed. Excise Tax: N/A
Maximum: 500,000 Doses
Minimum: 100 Doses



7. Tetanus, Reduced Diphtheria Toxoid, and Acellular Pertussis (TDaP)
Min. Shelf Life: 12 Months
Fed. Excise Tax: $2.25 per dose
Maximum: 850,000 Doses
Minimum: 100 Doses



8. Measles, Mumps, and Rubella
Min. Shelf Life: 12 Months
Fed. Excise Tax: $2.25 per dose
Maximum: 250,000 Doses
Minimum: 100 Doses



9. Meningococcal Conjugate (Groups A,C,Y &W)
Min. Shelf Life: 12 Months
Fed. Excise Tax: tiny_mce_marker.75 per dose
Maximum: 200,000 Doses
Minimum: 100 Doses



10. Human Papillomavirus (HPV9)
Min. Shelf Life: 12 Months
Fed. Excise Tax: tiny_mce_marker.75 per dose
Maximum: 300,000 Doses
Minimum: 100 Doses



11. Varicella
Min. Shelf Life: 12 Months
Fed. Excise Tax: tiny_mce_marker.75 per dose
Maximum: 150,000 Doses
Minimum: 10 Doses



12. Pneumococcal Conjugate (PCV13)
Min. Shelf Life: 12 Months
Fed. Excise Tax: tiny_mce_marker.75 per dose
Maximum: 500,000 Doses
Minimum: 100 Doses


13. Serogroup B Meningococcal
Min. Shelf Life: 12 Months
Fed. Excise Tax: tiny_mce_marker.75 per dose
Maximum: 200,000 Doses
Minimum: 100 Doses



All Vaccines are required to be delivered within 15 days after receipt of order.



The vaccines awarded under these contracts will be purchased for NCIRD's immunization awardees (the fifty state health departments, several large city programs and current and former U.S. Territories) to support adult immunization programs as provided under Section 317(j) of the Public Health Service Act. This acquisition will be conducted in accordance with FAR Part 12, Acquisition of Commercial Items. Vaccines shall be shipped F.O.B. Destination, as directed by delivery orders. The period of performance shall be 12 months from time of award. Any questions regarding this notice shall be submitted in writing to Christina McMichael at wpn6@cdc.gov. Telephone inquiries will not be honored.

.

Attachments

Files attached to this notice, newest first
File Type Posted
List_of_Questions_and_Answers_for_RFQ_75D301-19-R-67894_Vaccines_for_Adults_2019.docx DOCX document
75D301-19-R-67894_Vaccines_for_Adults_Solicitation.doc DOC document

On GovTribe

Work this opportunity on GovTribe

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity